Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-10

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We aim to clarify the relationship between sleep hygiene and the onset of sarcopenia or cognitive dysfunction using sleep time, arousal, and sleep quality as indicators in COPD or IPF patients, and clarify the effects of sleep hygiene on disease progression and life prognosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sarcopenia in COPD Patients: a French Study

NCT03111849

COPD

COMPLETED

Has Pulmonary Rehabilitation a Positive Impact on Sleep Quality in Patients Suffering From COPD ?

NCT03314558

COPD

COMPLETED

Cognitive Dysfunction in COPD Patients : Role in the Performance of Cognitive-motor Dual Task Situation?

NCT02493790

Chronic Obstructive Pulmonary Disease

COMPLETED

Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD

NCT07059637

COPD Emphysema Sarcopenia

RECRUITING NA

The Role of Physical Activity for Acute Exacerbations of COPD

NCT03855670

COPD

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) have been reported to be associated with a high rate of sleep-related disorders such as insomnia, sleep-related hypoventilation, and sleep apnea syndrome.Sleep-related disorders cause symptoms such as daytime sleepiness, decreased ADL, and depression, which causes cognitive dysfunction. Both COPD and IPF have been reported to be associated with cognitive dysfunction. Recently, it has been focused on the relationship between sleep-related disorders and sarcopenia. The relationship between sleep hygiene, cognitive dysfunction, and sarcopenia in the patients with COPD or IPF is not well understood.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Hygiene Sarcopenia Cognitive Function COPD IPF

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects with COPD or IPF.

Exclusion Criteria

* Subjects who have been hospitalized for exacerbation of respiratory failure within 1 month of study participation
* Subjects who have already been diagnosed with sarcopenia or cognitive dysfunction
* Subjects receiving long-term oxygen therapy (LTOT) or non-invasive ventilation therapy (NIV)
* Subjects with obstructive sleep apnea who are indicated for continuous positive airway pressure (CPAP)
* Subjects with severe complications such as cardiovascular disease, liver disease, renal disease, malignancy, and neurological disease.

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No